782493-24-7

Basic information

• Product Name: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester
• CAS NO: 782493-24-7
• Molecular Formula: C19H25NO4
• Molecular Weight: 331.412
• Mol File: 782493-24-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester(782493-24-7)
• EPA Substance Registry System: 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester(782493-24-7)

Safety Data

• Hazardous Substances Data: 782493-24-7(Hazardous Substances Data)

Usage

Description

1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is a chemical compound with a molecular formula of C21H25NO4 and a molecular weight of 355.43 g/mol. It is characterized by its potential applications in the pharmaceutical industry, particularly as a tautomerase ligand. Additionally, it may possess anti-inflammatory and anti-cancer properties, making it a promising candidate for further study and potential medical applications.

Uses

Used in Pharmaceutical Industry:
1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is used as a tautomerase ligand for [application reason] in the pharmaceutical industry. Its unique structure and properties make it a valuable compound for research and development of new drugs and treatments.
Used in Research and Development:
In the field of research and development, 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is used as a key compound for [application reason] in the development of novel drugs and treatments. Its potential anti-inflammatory and anti-cancer properties make it a promising candidate for further study and potential medical applications.
Used in Drug Design and Synthesis:
1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is utilized as a building block or intermediate in the design and synthesis of new pharmaceutical compounds. Its unique structure allows for the creation of novel drug candidates with potential therapeutic benefits.
Used in Drug Delivery Systems:
In the development of drug delivery systems, 1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester may be used as a component to enhance the delivery, bioavailability, and therapeutic outcomes of various drugs. Its properties could be harnessed to improve the efficacy of existing treatments and potentially reduce side effects.
Used in Anti-inflammatory and Anti-cancer Applications:
1(2H)-Pyridinecarboxylic acid, 4-[3-(ethoxycarbonyl)phenyl]-3,6-dihydro-, 1,1-dimethylethyl ester is explored for its potential use as an anti-inflammatory and anti-cancer agent. Its properties may contribute to the development of new treatments for various inflammatory and cancer-related conditions, offering patients improved options for managing their health.

Upstream product

• 4334-87-6 [3-(ethoxycarbonyl)phenyl]boronic acid 
• 138647-49-1 4-Trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 58313-23-8 3-iodobenzoic acid methyl ester 
• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Downstream Products

• 1263775-59-2 N-methyl-3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-((R)-1-phenyl-ethyl)-benzamide 
• 1263776-11-9 3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-benzoic acid ethyl ester 
• 1263776-13-1 3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-benzoic acid 
• 1263775-57-0 3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-(R)-1,2,3,4-tetrahydro-naphthalene-1-yl-benzamide 
• 1263775-58-1 N-methyl-3-{1-[2-(5-methyl-3-trifluoromethyl-pyrazol-1-yl)-acetyl]-piperidin-4-yl}-N-(R)-1,2,3,4-tetrahydro-naphthalene-1-yl-benzamide 
• 1016979-38-6 tert-butyl 4-(3-(2-hydroxypropan-2-yl)phenyl)piperidine-1-carboxylate 
• 1017018-87-9 2-(3-(piperidin-4-yl)phenyl)propan-2-ol 
• 782493-05-4 ethyl 3-[1-((1R,3S)-3-(1R-hydroxyethyl)-3-{[6-(trifluoromethyl)-2H-1,3-benzoxazin-3(4H)-yl]carbonyl}cyclopentyl)piperidin-4-yl]benzoate 
• 782492-16-4 C₃₃H₄₁F₃N₂O₄ 
• 782492-97-1 C₃₃H₄₁F₃N₂O₄ 
• 782492-14-2 cis ethyl 3-[1-((1R,3S)-3-isopropyl-3-{[6-(trifluoromethyl)-2H-1,3-benzoxazin-3(4H)-yl]carbonyl}cyclopentyl)piperidin-4-yl]benzoate 

Relevant articles and documents

CCR2 MODULATORS

Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (I) and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of CCR2 receptors.

MICROBIOCIDAL HETEROCYCLES

The present invention relates to heterocyclic compounds of formula I which have microbiocidal activity, in particular fungicidal activity as well as methods of using the compounds of formula (I) to control microbes: wherein A is x-C(R10R11

Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists

This report describes replacement of the 4-(4-fluorophenyl)piperidine moiety in our CCR2 antagonists with 4-heteroaryl piperidine and 4-(carboxyphenyl)-piperidine subunits. Some of the resulting analogs retained potency in our CCR2 binding assay and had i